Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Breast Cancer Risk clinical trials
2 of 5 indexed Breast Cancer Risk trials are currently recruiting.
Corpus placement: #3,391 of 28,707 conditions by registered trial count.
5 US clinical trials · 2 currently recruiting · #3,391 of 28,707 conditions by registered trial count
Breast Cancer Risk: 5 US clinical trials tracked, 2 recruiting.
Breast Cancer Risk is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. The most active sponsor is Georgetown University, running 1 of these trials.
Enrollment posture brief
Registry condition breast-cancer-risk
OPEN 2 | RECR 40% | LATE 0 | EARLY 0 | RANK #3391 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Achondroplasia (40% recruiting · 10 trials)
Breast Cancer Risk lists 2 open slots (40% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Breast Cancer Risk on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Breast Cancer Risk is recruiting below its size-band peers.
2 of 5 indexed trials (40%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Breast Cancer Risk research.
Georgetown University accounts for 1 of 5 trials (20%). 5 distinct sponsors appear on at least one study for this condition label.
-
Typical Breast Cancer Risk enrolment sits around 560 participants.
Median target enrolment is 560 among the 5 trials that report a genuine target (sentinel values excluded). 1 of those (20%) plan for fewer than 100 participants.
-
Breast Cancer Risk splits between interventional and observational designs.
3 interventional and 2 observational studies make up this index (60% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
5 total, page 1 of 1
Rutgers University Study of the Genetics of Breast Cancer.
Rutgers, The State University of New Jersey
NCT06773897
Mirai-MRI: Validation of AI Models for Breast Cancer Risk
University of California, San Francisco
NCT07121972
Uptake of Genetic Counseling Among African American Women
University of Illinois at Chicago
NCT04082117
Peer Support For Young Adult Women With High Breast Cancer Risk
Georgetown University
NCT04248257
Effects of Tirzepatide on Blood, Imaging and Breast Tissue Biomarkers
University of Kansas Medical Center
NCT06485089
Phase Distribution
Phase data not available
Top Sponsors
Named interventions
Most-linked intervention names on Breast Cancer Risk records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Breast Cancer Risk trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Breast Cancer Risk page
5 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Breast Cancer Risk trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Georgetown University sponsors the most Breast Cancer Risk trials on record, review their full trial history before evaluating a specific study. See Georgetown University's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Breast Cancer Risk condition card totals 5 registered trials; most-linked intervention Community peer coaching; top US site state New Jersey. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.